skip navigation

Skip Nav

Clinical Guidelines Portal

skip navigation

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Guidelines Panel Members

(Last updated:3/28/2014; last reviewed:3/28/2014)

Members of the Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission

Revisions to the July 31, 2012, Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal Transmission in the United States have been made by the Department of Health and Human Services (HHS) Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission (a Working Group of the Office of AIDS Research Advisory Council).

Members of the Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission

Members of the Panel

Erika Aaron, MSN, ANP, RNP

Drexel University College of Medicine, Philadelphia, PA

Elaine J. Abrams, MD

Columbia University, New York, NY

Jean Anderson, MD

Johns Hopkins University School of Medicine, Baltimore, MD

Liz Barr, MS

Madison, WI

Brookie M. Best, PharmD, MAS  University of California San Diego, La Jolla, CA and Rady Children’s Hospital, San Diego, CA
Andrea Ciaranello, MD, MPH
Massachusetts General Hospital, Harvard Medical School, Boston, MA

Rana Chakraborty, MD, MS, PhD

Emory University School of Medicine, Atlanta, GA

Susan E. Cohn, MD, MPH

Northwestern University Feinberg School of Medicine, Chicago, IL

Susan Cu-Uvin, MD

The Miriam Hospital, Brown University, Providence, RI

Stephanie Deyo
Seattle, WA

Judith Feinberg, MD

University of Cincinnati College of Medicine, Cincinnati, OH

Patricia M. Flynn, MD

St. Jude Children’s Research Hospital, Memphis, TN

Mary Glenn Fowler, MD, MPH

Johns Hopkins University School of Medicine, Baltimore, MD

Gweneth B. Lazenby, MD, MSCR
Medical University of South Carolina, Charleston, SC
Judy Levison, MD, MPH
Baylor College of Medicine, Houston, TX

Robert Maupin, MD

Louisiana State University Health Sciences Center, New Orleans, LA

Howard Minkoff, MD

Maimonides Medical Center, State University of New York Brooklyn, Brooklyn, NY

Mark Mirochnick, MD

Boston Medical Center, Boston, MA

Fatima Y. Prioleau, MA

Brooklyn, NY

Stephen A. Spector, MD

University of California, San Diego, La Jolla, CA and Rady Children's Hospital, San Diego, CA

Kathleen E. Squires, MD

Thomas Jefferson University, Philadelphia, PA

Meg Sullivan, MD

Boston Medical Center, Boston, MA

Ruth Tuomala, MD

Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Geoffrey A. Weinberg, MD

University of Rochester School of Medicine and Dentistry, Rochester, NY

Panel Executive Secretary

Lynne Mofenson, MD

National Institutes of Health, Rockville, MD

Ex Officio Member

Deborah Cohan, MD

National Perinatal HIV Hotline, San Francisco, CA

Members from the Department of Health and Human Services

Brian Feit, MPA

Health Resources and Services Administration, Rockville, MD

Denise Jamieson, MD, MPH

Centers for Disease Control and Prevention, Atlanta, GA

Steve Nesheim, MD

Centers for Disease Control and Prevention, Atlanta, GA

Polly E. Ross, MD
Health Resources and Services Administration, Rockville, MD 

Alan Shapiro, MD, PhD

Food and Drug Administration, Rockville, MD

George K. Siberry, MD, MPH  National Institutes of Health, Rockville, MD 

D. Heather Watts, MD

National Institutes of Health, Rockville, MD*

Nonvoting Observers from the François-Xavier Bagnound Center

Carolyn Burr, RN, EdD

François-Xavier Bagnoud Center, Rutgers School of Nursing, Newark, NJ

 

Deborah Storm, MSN, PhD

 

François-Xavier Bagnoud Center, Rutgers School of Nursing, Newark, NJ

*Moved to Office of Global AIDS Coordinator, State Department